Hungary's Richter announces acquisition of stake in U.S.-based Granata Bio

May 13 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says:

• ANNOUNCES ACQUISITION OF A SIGNIFICANT STAKE IN U.S.-BASED GRANATA BIO -STATEMENT

• IT WILL BECOME A MAJOR INVESTOR IN GRANATA BIO AND GAIN A SEAT ON GRANATA BIO'S BOARD OF DIRECTORS -STATEMENT

• COMPANIES SIGNED A BINDING TERM SHEET FOR THE CO-DEVELOPMENT OF BEMFOLA FOR THE U.S. MARKET

• BEMFOLA IS RICHTER'S RECOMBINANT FOLLICLE STIMULATING HORMONE PRODUCT

• COMPANIES SIGNED A ROYALTY PURCHASE AGREEMENT FOR GRANATA BIO'S HUMAN MENOPAUSAL GONADOTROPIN IN THE US, SECURING FUTURE ROYALTY INCOME FOR RICHTER

Source text: [https://bet.hu/newkibdata/129255522/GranataBio_May2025_EN.pdf]